Fish oil for nerve pain from bortezomib in multiple myeloma
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study tests whether taking fish oil can reduce nerve pain, tingling, or numbness that bortezomib chemotherapy often causes in people with multiple myeloma. If you are starting bortezomib for the first time, you may be able to join and help find a way to prevent this side effect.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with multiple myeloma (a type of blood cancer).
- You are scheduled to receive bortezomib (a chemotherapy drug) as your first treatment.
- You do not already have nerve damage symptoms like tingling or numbness in your hands or feet.
- You are not pregnant or breastfeeding and can take medications reliably.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking mecobalamin (a form of vitamin B12) can prevent or reduce nerve pain and numbness caused by taxane chemotherapy. It may help people getting chemo for several types of cancer.
This trial studies whether botulinum toxin A (Botox) injections can reduce nerve pain caused by chemotherapy in people with breast cancer. It may help if your pain started soon after chemotherapy and fits the trial’s specific nerve-pain pattern.
This trial tests if adding fenofibrate to standard treatment (VRd) can prevent nerve damage (peripheral neuropathy) caused by bortezomib in patients with newly diagnosed multiple myeloma. If you are starting VRd therapy, this study may help reduce pain or numbness from the chemotherapy.
This trial tests whether a blend of CBG and CBD oils can help relieve nerve pain, tingling, or weakness caused by platinum-based chemotherapy in people with certain gastrointestinal cancers. If you have had colorectal, biliary, pancreatic, esophageal, gastric, or small intestinal cancer and completed chemo in the last 2 years, you may be able to join.
This trial tests whether ketotifen can protect against nerve damage (called peripheral neuropathy) caused by oxaliplatin, a common chemotherapy used for stage III colon cancer. If it works, it may help reduce tingling, numbness, or burning pain in the hands and feet.
This study tests a diet program delivered online to help reduce nerve damage symptoms like numbness and tingling caused by chemotherapy. It is for cancer survivors who completed treatment and still have these symptoms.
Hear when a new Multiple myeloma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.